Insider Transactions in Q1 2023 at Checkpoint Therapeutics, Inc. (CKPT)
Insider Transaction List (Q1 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 31
2023
|
William Garrett Gray Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
100,000
+39.78%
|
-
|
|
Mar 31
2023
|
James F Oliviero Iii CEO, President and Director |
BUY
Grant, award, or other acquisition
|
Direct |
250,000
+38.81%
|
-
|
|
Mar 31
2023
|
Fortress Biotech, Inc. |
BUY
Grant, award, or other acquisition
|
Direct |
35,714
+2.27%
|
-
|
|
Mar 02
2023
|
William Garrett Gray Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
3,591
-6.53%
|
$17,955
$5.0 P/Share
|
|
Mar 02
2023
|
James F Oliviero Iii CEO, President and Director |
SELL
Open market or private sale
|
Direct |
5,483
-3.67%
|
$27,415
$5.0 P/Share
|
|
Feb 27
2023
|
William Garrett Gray Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
7,500
+12.01%
|
-
|
|
Feb 27
2023
|
William Garrett Gray Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
1,914
-3.88%
|
$7,656
$4.66 P/Share
|
|
Feb 27
2023
|
James F Oliviero Iii CEO, President and Director |
BUY
Grant, award, or other acquisition
|
Direct |
15,000
+9.11%
|
-
|
|
Feb 27
2023
|
James F Oliviero Iii CEO, President and Director |
SELL
Open market or private sale
|
Direct |
5,548
-3.96%
|
$22,192
$4.65 P/Share
|
|
Feb 01
2023
|
James F Oliviero Iii CEO, President and Director |
SELL
Open market or private sale
|
Direct |
10,261
-5.33%
|
$41,044
$4.77 P/Share
|
|
Feb 01
2023
|
William Garrett Gray Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
3,154
-6.0%
|
$12,616
$4.79 P/Share
|
|
Jan 10
2023
|
James F Oliviero Iii CEO, President and Director |
SELL
Open market or private sale
|
Direct |
3,817
-1.95%
|
$22,902
$6.75 P/Share
|
|
Jan 10
2023
|
William Garrett Gray Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
1,858
-3.42%
|
$11,148
$6.75 P/Share
|
|
Jan 05
2023
|
Fortress Biotech, Inc. |
BUY
Grant, award, or other acquisition
|
Direct |
368,907
+19.7%
|
-
|